Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease

被引:39
|
作者
Giuseppe Paradies [1 ]
Valeria Paradies [1 ]
Francesca M Ruggiero [1 ]
Giuseppe Petrosillo [2 ]
机构
[1] Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70126 Bari, Italy
[2] Institute of Biomembranes and Bioenergetics, National Research Council, 70126 Bari, Italy
关键词
Oxidative stress; Cardiolipin; Mitochondrial bioenergetics; Antioxidants; Nonalcoholic fatty liver disease;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease(NAFLD) is today considered the most common form of chronic liver disease, affecting a high proportion of the population worldwide. NAFLD encompasses a large spectrum of liver damage, ranging from simple steatosis to steatohepatitis, advanced fibrosis and cirrhosis. Obesity, hyperglycemia, type 2 diabetes and hypertriglyceridemia are the most important risk factors. The pathogenesis of NAFLD and its progression to fibrosis and chronic liver disease is still unknown. Accumulating evidence indicates that mitochondrial dysfunction plays a key role in the physiopathology of NAFLD, although the mechanisms underlying this dysfunction are still unclear. Oxidative stress is considered an important factor in producing lethal hepatocyte injury associated with NAFLD. Mitochondrial respiratory chain is the main subcellular source of reactive oxygen species(ROS), which may damage mitochondrial proteins, lipids and mitochondrial DNA. Cardiolipin, a phospholipid located at the level of the inner mitochondrial membrane, plays an important role in several reactions and processes involved in mitochondrial bioenergetics as well as in mitochondrial dependent steps of apoptosis. This phospholipid is particularly susceptible to ROS attack. Cardiolipin peroxidation has been associated with mitochondrial dysfunction in multiple tissues in several physiopathological conditions, including NAFLD. In this review, we focus on the potential roles played by oxidative stress and cardiolipin alterations in mitochondrial dysfunction associated with NAFLD.
引用
收藏
页码:14205 / 14218
页数:14
相关论文
共 50 条
  • [31] Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
    Chang, Eunha
    Chang, Jae Seung
    Kong, In Deok
    Baik, Soon Koo
    Kim, Moon Young
    Park, Kyu-Sang
    GUT AND LIVER, 2022, 16 (02) : 171 - 189
  • [32] Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
    Peng, Kang-Yu
    Watt, Matthew J.
    Rensen, Sander
    Greve, Jan Willem
    Huynh, Kevin
    Jayawardana, Kaushala S.
    Meikle, Peter J.
    Meex, Ruth C. R.
    JOURNAL OF LIPID RESEARCH, 2018, 59 (10) : 1977 - 1986
  • [33] The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus
    Liu, Xiaolin
    Zhang, Jingyi
    Ming, Yanan
    Chen, Xiaoyu
    Zeng, Minde
    Mao, Yimin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1152 - 1159
  • [34] Conventional inflamation and oxidative stress markers of the nonalcoholic fatty liver disease diagnosed patients
    Muratoglu, S.
    Bilgihan, A.
    Degertekin, B.
    Erkan, G.
    Ercin, U.
    Caliskan, A.
    FEBS JOURNAL, 2015, 282 : 147 - 147
  • [35] Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease
    Chen, Xu
    Sun, Xiaoyuan
    Shen, Tianran
    Chen, Qian
    Chen, Shen
    Pang, Juan
    Mi, Jiaxin
    Tang, Yi
    You, Yiran
    Xu, Huihui
    Ling, Wenhua
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 160 : 191 - 198
  • [36] Myocardial oxidative stress in an experimental model of nonalcoholic fatty liver disease: role of silibinin
    Malaguarnera, M.
    Salamone, F.
    La Delia, F.
    Galvano, F.
    Volti, G. Li
    FEBS JOURNAL, 2011, 278 : 465 - 465
  • [37] Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease
    Jiang, Guangyu
    Chen, Dayin
    Li, Wenpeng
    Liu, Chengcheng
    Liu, Jiguang
    Guo, Yingxue
    PHARMACEUTICAL BIOLOGY, 2020, 58 (01) : 1177 - 1183
  • [38] Levels of the Oxidative Stress Marker γ-Glutamyltranspeptidase at Different Stages of Nonalcoholic Fatty Liver Disease
    Irie, M.
    Sohda, T.
    Iwata, K.
    Kunimoto, H.
    Fukunaga, A.
    Kuno, S.
    Yotsumoto, K.
    Sakurai, K.
    Iwashita, H.
    Hirano, G.
    Ueda, S. I.
    Yokoyama, K.
    Morihara, D.
    Nishizawa, S.
    Anan, A.
    Takeyama, Y.
    Sakamoto, M.
    Shakado, S.
    Sakisaka, S.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (03) : 924 - 933
  • [39] Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation
    Li, Zeyu
    Wang, Hong
    Wu, Kanglin
    Zhang, Lianfeng
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (12)
  • [40] Dual mechanistic significance of oxidative stress in human nonalcoholic fatty liver disease (NAFLD)
    Videla, LA
    Rodrigo, R
    Araya, J
    Poniachik, J
    SFRR: PROCEEDINGS OF THE XII BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, 2004, : 261 - 266